| MVCAX | TCMVX | MVCAX / TCMVX | |
| Total Expense Ratio | 0.97 | 0.80 | 121% |
| Annual Report Gross Expense Ratio | 0.98 | 0.80 | 122% |
| Fund Existence | 25 years | 24 years | - |
| Gain YTD | 7.715 | 14.950 | 52% |
| Front Load | 6% | 6% | 100% |
| Min. Initial Investment | 1000 | 2500 | 40% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 16.8B | 1.67B | 1,007% |
| Annual Yield % from dividends | 1.16 | 1.35 | 86% |
| Returns for 1 year | 9.57 | 20.75 | 46% |
| Returns for 3 years | 21.83 | 45.35 | 48% |
| Returns for 5 years | 9.01 | 2.97 | 303% |
| Returns for 10 years | 76.09 | 0.39 | 19,665% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ISCCX | 35.20 | N/A | N/A |
| Federated Hermes Intl Small-Mid Co C | |||
| VTPSX | 185.79 | N/A | N/A |
| Vanguard Total Intl Stock Idx InstlPls | |||
| TTISX | 15.46 | N/A | N/A |
| Nuveen Quant Intl Sm Cap Eq Retirement | |||
| VGIRX | 16.34 | N/A | N/A |
| Virtus Duff & Phelps Global Infras R6 | |||
| JFNNX | 77.97 | -2.10 | -2.62% |
| Janus Henderson Global Life Sciences N | |||